相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Smad-independent transforming growth factor-β regulation of early growth response-1 and sustained expression in fibrosis -: Implications for scleroderma
Swati Bhattacharyya et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate
Jaspreet Pannu et al.
ARTHRITIS AND RHEUMATISM (2008)
Molecular ablation of transforming growth factor β signaling pathways by tyrosine kinase inhibition:: The coming of a promising new era in the treatment of tissue fibrosis
Joel Rosenbloom et al.
ARTHRITIS AND RHEUMATISM (2008)
Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
Andrew Leask
CELLULAR SIGNALLING (2008)
Fibrosis in systemic sclerosis
John A. Varga et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways
Jaspreet Pannu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors
Carsten Schubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
Platelet-derived growth factor-β receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing
Vineeth S. Rajkumar et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Acetaldehyde inhibits PPARγ via H2O2-mediated c-Abl activation in human hepatic stellate cells
Elisabetta Ceni et al.
GASTROENTEROLOGY (2006)
Transforming growth factor β activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures
Mark C. Wilkes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The early-immediate gene EGR-1 is induced by transforming growth factor-β and mediates stimulation of collagen gene expression
Shu-Jen Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Early growth response-1 in cardiovascular pathobiology
LM Khachigian
CIRCULATION RESEARCH (2006)
Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β:: implications for carcinogenesis
D Javelaud et al.
ONCOGENE (2005)
Modulation of the p38 MAR (mitogen-activated protein kinase) pathway through Bcr/Abl:: implications in the cellular response to Ara-C
VJSA Lobo et al.
BIOCHEMICAL JOURNAL (2005)
ABL oncogenes and phosphoinositide 3-kinase:: Mechanism of activation and downstream effectors
NG Kharas et al.
CANCER RESEARCH (2005)
Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis
T Takahashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Imatinib mesylate blocks a non-smad TGF-beta pathway and reduces renal fibrogenesis in vivo
SN Wang et al.
FASEB JOURNAL (2005)
Ets ternary complex transcription factors
G Buchwalter et al.
GENE (2004)
Regulation of PDGF and its receptors in fibrotic diseases
JC Bonner
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor β responses in skin fibroblasts
Y Mori et al.
ARTHRITIS AND RHEUMATISM (2004)
Targeted disruption of TGF-β/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma
G Lakos et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Recent advances in fibroblast signaling and biology in scleroderma
J Pannu et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
How do Abl family kinases regulate cell shape and movement?
SE Hernandez et al.
TRENDS IN CELL BIOLOGY (2004)
Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment
JM Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Biphasic role of TGF-β1 in signal transduction and crosstalk
CE Wenner et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Sustained activation of fibroblast transforming growth Factor-β/Smad signaling in a murine model of scleroderma
S Takagawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia
P La Rosée et al.
EXPERIMENTAL HEMATOLOGY (2002)
Balancing the activation state of the endothelium via two distinct TGF-β type I receptors
MJ Goumans et al.
EMBO JOURNAL (2002)
Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension
PJ Woodring et al.
JOURNAL OF CELL BIOLOGY (2002)
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
T Virolle et al.
NATURE CELL BIOLOGY (2001)
p160 Bcr mediates platelet-derived growth factor activation of extracellular signal-regulated kinase in vascular smooth muscle cells
W Che et al.
CIRCULATION (2001)
c-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases
AM Teckchandani et al.
ONCOGENE (2001)
EGR1 target genes in prostate carcinoma cells identified by microarray analysis
J Svaren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Role for Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage
K Yoshida et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Modulation of endogenous smad expression in normal skin fibroblasts by transforming growth factor-β
Y Mori et al.
EXPERIMENTAL CELL RESEARCH (2000)
The c-Abl tyrosine kinase contributes to the transient activation of MAP kinase in cells plated on fibronectin
MW Renshaw et al.
ONCOGENE (2000)
JAK-STAT signaling activated by Abl oncogenes
NN Danial et al.
ONCOGENE (2000)